4.8 Article

Metformin as a Tool to Target Aging

Journal

CELL METABOLISM
Volume 23, Issue 6, Pages 1060-1065

Publisher

CELL PRESS
DOI: 10.1016/j.cmet.2016.05.011

Keywords

-

Funding

  1. NIA NIH HHS [R24 AG044396, R01 AG046949, P30 AG021332, P30 AG038072, P01 AG027734, R37 AG018381, P01 AG021654] Funding Source: Medline
  2. NIDDK NIH HHS [U01 DK048349] Funding Source: Medline

Ask authors/readers for more resources

Aging has been targeted by genetic and dietary manipulation and by drugs in order to increase lifespan and health span in numerous models. Metformin, which has demonstrated protective effects against several age-related diseases in humans, will be tested in the TAME (Targeting Aging with Metformin) trial, as the initial step in the development of increasingly effective next-generation drugs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available